4th Annual Biomarker and Companion Diagnostics Conference MarketsandMarkets

7th-8th February 2019

The Westin San Diego Gaslamp Quarter 910 Broadway Cir, San Diego, CA 92101, USA

26+

Speakers

20+

Sponsors

100+

Attendees

10+

Networking Hours

3+

Sessions

Biomarker is constantly evolving as the latent for the development of innovative drugs and diagnostic assays for early detection of disease. The major developments are witnessed in immune therapies where breakthroughs will be appearing soon.

The 4th Annual Biomarker and Companion Diagnostics Conference scheduled to be held on 7th-8th February 2019 in San Diego, CA would address the gaps between early stage biomarker development and the commercialization stage of biomarkers. Regarding commercialization of biomarkers, leading industry and academic experts would share their case studies focusing on advancements in the companion diagnostics area. The keynote presentations would also help the attendees understand the issues related to clinical translation of biomarkers.

Tag Line
Learn from 20+ industry leading speakers who will be sharing their presentations and use cases on Non-invasive diagnosis of lung cancer, disruptive technologies in biomarker research, Next-generation CAR T-cells, Cloud software solutions for Clinical assays experiences.
Tag Line
Facilitated networking sessions to ensure quality interactions which include one on one query handling by biomarker experts and the opportunity to develop long-lasting business relationships and networking opportunities with senior peers.
Tag Line
Latest updates on regulatory guidelines and approvals, NGS and novel technologies in biomarker discovery, Commercialization of biomarkers in therapeutic and CDx applications with senior leaders from the Biomarker Industry.

We also have a UK Edition which will be held on 3 - 4 October 2019. View more details about the conference here.

We will soon be announcing the Dates and Venue for the 5th Biomarker and Companion Diagnostics Conference 2020. Email us on [email protected] to book your place at the conference.

WHAT TO EXPECT

  • Clinical Biomarker Identification & Qualification
  • Biomarker and Personalized Medicine
  • Commercializing Biomarkers in Therapeutic and Companion Diagnostic Applications

Researchers, scientists, clinicians, academicians and professionals working in Biomarker discovery/development, Translational research, Clinical Biomarker, Biomarkers in IO and Neurological disorders, Imaging Biomarkers, Pathology, Companion Diagnostics

  • Clinical biomarker identification and qualification
  • Biomarkers and personalized medicine
  • Assay development and validation

CONFERENCE SPEAKERS

ADVISORS

Steve Richards

Steve Richards

Investigator, Biomarker Expert , Novartis

Katherine Call

Katherine Call

Head, Proteogenomics , Genzyme Sanofi

SPEAKERS

James McDuffie

James McDuffie

Scientific Director , Janssen Research & Development

Sarah Wang

Sarah Wang

Director of Bioinformatics and Data Science , CareDx

Bianca Heinrich

Bianca Heinrich

Senior Scientist , AbCam

Timothy Tak-Chun

Timothy Tak-Chun

Senior Medical Science Director, ACT Genomics

John Todd

John Todd

Senior Vice President and Chief Scientific Officer , Singulex

Catherine Sanders

Catherine Sanders

Senior Director, Research and Business Development , Adaptive Biotechnologies

Zhen Mahoney

Zhen Mahoney

Head, Business Development , Asuragen

Rolf Muller

Rolf Muller

CEO , BioFluidica

Thomas Briggs

Thomas Briggs

Senior Key Account and Business Development Manager , Becton Dickinson

Ken Bloom

Ken Bloom

Head of Pathology, Nucleai

Will Westra

Will Westra

Senior Director of Business Development, Oxford BioDynamics

Jeff Miller

Jeff Miller

CEO, CSO , Invivoscribe

Adil Daud

Adil Daud

Director, Melanoma Program, UCSF Medical Center

Steve Richards

Steve Richards

Investigator, Biomarker Expert , Novartis

Paul Wood

Paul Wood

Director, Metabolomics Unit, Professor, Associate Dean of Research , Lincoln Memorial University

Mark Ma

Mark Ma

Head, Bioanalytical and Biomarker Development , Alexion Pharmaceuticals

Qihong Huang

Qihong Huang

Senior Principal Scientist , Boehringer Ingelheim

Julianne Smith

Julianne Smith

Head, Translational Medicine , Cellectis

Joshua LaBaer

Joshua LaBaer

Director, Executive Director and Professor , University of Arizona

Jaya Goyal

Jaya Goyal

Vice President, Bioanalytical, Pharmacology and Biomarker Development , Wave Lifesciences

Mike Baratta

Mike Baratta

Scientific Director, Translational Biomarker Research , Takeda

Iman Jilani

Iman Jilani

Director, Oncology Clinical Assay Group , Pfizer

Howard Federoff

Howard Federoff

Professor of Neurology , University of California

John Rossi

John Rossi

Vice President, Head, Translational Medicine, , Syncopation Lifesciences

Pallavi Sachdev

Pallavi Sachdev

Senior Director, Clinical Pharmacology and Translational Medicine , Eisai

Katherine Call

Katherine Call

Head, Proteogenomics , Genzyme Sanofi

ENQUIRE NOW

PARTNERS

LOCATION

Venue

The Westin San Diego Gaslamp Quarter 910 Broadway Cir, San Diego, CA 92101, USA

PAST EVENT GALLERY